Itching for innovation: the role of aryl hydrocarbon receptor agonists as a future therapy for atopic dermatitis
Itching for innovation: the role of aryl hydrocarbon receptor agonists as a future therapy for atopic dermatitis
About this course
- Released:
- Expires: March 19, 2035
Target Audience
This activity is intended for practicing dermatologists and other physicians involved in the treatment and management of diseases of the skin.
Learning Objective
To understand the role of aryl hydrocarbon receptor (AHR) agonists as a future treatment for atopic dermatitis (AD).
Accreditation and Designation Statement
Once the test is passed, a certificate of completion will be generated. The learning activity can be added to the Royal College of Physicians' CPD diary as a self-certified entry.
Activity Disclosures
No commercial support has been accepted related to the development or publication of this activity.